ESC 365 - LOT-MDR: Loop diuretic dose intensification versus adjuvant thiazide for diuretic resistance in acute heart failure

ESC2025 Premium Access

LOT-MDR: Loop diuretic dose intensification versus adjuvant thiazide for diuretic resistance in acute heart failure

Session: Late-Breaking Clinical Trials: advances in heart failure care

Topic: Pharmacotherapy

Speaker: Professor Z. Cox (Nashville, US)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Professor Zachary Cox

Lipscomb University College of Pharmacy, Nashville (United States of America)

4 presentations

1 follower

2 more presentations in this session

Lifetime Benefits of Combination Therapy in HFpEF

Speaker: Doctor M. Vaduganathan (Boston, US)

ENVAD-HF: sacubitril/valsartan in Heartmate 3 LVAD recipients

Speaker: Professor M. Cikes (Zagreb, HR)

Access the full session

Late-Breaking Clinical Trials: advances in heart failure care

Speakers: Professor Z. Cox, Doctor M. Vaduganathan, Professor M. Cikes

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources